Literature DB >> 9010646

NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus.

G D Champion1, P H Feng, T Azuma, D E Caughey, K H Chan, S Kashiwazaki, H C Liu, A R Nasution, M Nobunaga, S Prichanond, T P Torralba, V Udom, D Utis, S R Wang, W S Wong, D J Yang, M C Yoo.   

Abstract

The problem of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal toxicity was reviewed by members of the Asia Pacific League of Associations for Rheumatology (APLAR) in a consensus conference in September 1992. This paper by the participants presents the consensus conclusions incorporating knowledge from recent publications. There had been a high level of concern that much of the toxicity had resulted from extensive and indiscriminate prescribing of NSAIDs. The implementation of evidence-based guidelines was considered likely to be able to effect a substantial reduction in toxicity without significant loss of overall therapeutic benefit. The evidence from which such guidelines could be developed is critically appraised.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010646     DOI: 10.2165/00003495-199753010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  85 in total

Review 1.  Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.

Authors:  S H Roth; R E Bennett
Journal:  Arch Intern Med       Date:  1987-12

2.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

Review 3.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

Review 4.  Prostaglandins in the gut and their relationship to non-steroidal anti-inflammatory drugs.

Authors:  E L Semble; W C Wu
Journal:  Baillieres Clin Rheumatol       Date:  1989-08

5.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

6.  Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.

Authors:  N M Agrawal; S Roth; D Y Graham; R H White; B Germain; J A Brown; S C Stromatt
Journal:  Ann Intern Med       Date:  1991-08-01       Impact factor: 25.391

7.  Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.

Authors:  G Singh; D R Ramey; D Morfeld; H Shi; H T Hatoum; J F Fries
Journal:  Arch Intern Med       Date:  1996-07-22

8.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22

9.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

Authors:  M C Allison; A G Howatson; C J Torrance; F D Lee; R I Russell
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

10.  Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.

Authors:  J B Raskin; R H White; J E Jackson; A L Weaver; E A Tindall; R B Lies; D S Stanton
Journal:  Ann Intern Med       Date:  1995-09-01       Impact factor: 25.391

View more
  4 in total

Review 1.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

2.  An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands.

Authors:  R M Herings; O H Klungel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Economic evaluation of tramadol/paracetamol combination tablets for osteoarthritis pain in the Netherlands.

Authors:  Hiltrud Liedgens; Mark J C Nuijten; Barbara Poulsen Nautrup
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  Mutual Amide Prodrug of Etodolac-glucosamine: Synthesis, Characterization and Pharmacological Screening.

Authors:  Preeti Pandey; S Pandey; Shaifali Dubey
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.